Samatasvir [CAS 1312547-19-5]
Partner: MedChemexpress LLC
| CAS No: | 1312547-19-5 |
| Applications: | COVID-19-anti-virus |
| MW: | 885.06 |
| Formula: | C47H48N8O6S2 |
| SMILES: | O=C(OC)N[C@H](C1=CC=CC=C1)C(N2[C@H](C3=NC=C(C4=CC=C(C5=CSC6=C5SC=C6C7=CC=C8N=C([C@H]9N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC9)NC8=C7)C=C4)N3)CCC2)=O |
| Purity: | 99.39 |
| Description: | Samatasvir (IDX71) is a potent, orally active NS5A inhibitor of HCV replication. Samatasvir is effective and selective against infectious HCV and replicons, with EC50s falling within a tight range of 2 to 24 pM in genotype 1 through 5 replicons[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
